IOVANCE BIOTHERAPEUTICS, INC. Increase (Decrease) in Deferred Income Taxes
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Increase (Decrease) in Deferred Income Taxes of $20.80 million for the 3-month period ending 2017-12-31, per its 10-K filed 2019-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2019-02-28
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in deferred income taxes for the quarter ending 2017-12-31 was $20.80M.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in deferred income taxes for fiscal 2017 was $20.80M.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|---|
| 2017-12-31 | $20.80M 10-K · filed 2019-02-28 | $20.80M 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |